Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Genuit Group (GEN) by Steve Moore in ShareProphets
- Watch Persimmon (PSN) by Harvey Jones in The Motley Fool
- Sell Headlam Group (HEAD) by Steve Moore in ShareProphets
- Buy Marwyn Value Investors Limited (MVI) by Tom Winnifrith in ShareProphets
- Buy Marwyn Value Investors Limited (MVI) by Steve Moore in ShareProphets
- Watch Greggs (GRG) by Zaven Boyrazian in The Motley Fool
- Watch Savannah Resources (SAV) by Ben McPoland in The Motley Fool
- Watch Fresnillo (FRES) by Andrew Mackie in The Motley Fool
- Buy Smith & Nephew (SN.) by Goldman Sachs
- Neutral Whitbread (WTB) by Goldman Sachs
- Overweight Young & Co's Brewery 'A' Shares (YNGA) by JP Morgan
- Hold Creo Medical Group (CREO) by Ben McPoland in The Motley Fool
- Avoid FDM Group (Holdings) (FDM) by Steve Moore in ShareProphets
- Buy Ariana Resources (AAU) by Steve Moore in ShareProphets
- Avoid Ibstock (IBST) by Steve Moore in ShareProphets
- Buy Ariana Resources (AAU) by Tom Winnifrith in ShareProphets
- Neutral SSE (SSE) by UBS
- Neutral Kingfisher (KGF) by UBS
- Neutral Johnson Matthey (JMAT) by UBS
- Hold Topps Tiles (TPT) by Canaccord Genuity
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,453 open tips for GSK (GSK)
| Latest Bid : 1,912.00p | Latest Ask : 1,913.00p |
| High Today : 1,928.00p | Low Today : 1,905.79p |
| This Years High : 2,208.00p | This Years Low : 1,344.00p |
| Volume : 1,762,224 | MKT Cap : £79376.75M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Add | Simon Watkins | Premium Only | 2026-05-07 10:20:00 07/05/2026 | 1.89% |
| Neutral | Citi | Premium Only | 2026-05-06 06:15:00 06/05/2026 | – |
| Hold | LBBW | Premium Only | 2026-04-30 10:42:00 30/04/2026 | -1.39% |
| Underweight | Barclays | Premium Only | 2026-04-30 05:48:00 30/04/2026 | -0.42% |
| Neutral | Goldman Sachs | Premium Only | 2026-04-30 05:10:00 30/04/2026 | – |
GSK (GSK) Active Short Positions
| Fund Manager | Position | Date |
|---|---|---|
| Millennium International Management LP | 0.5% | 12/05/2026 |
| Citadel Advisors LLC | 0.51% | 06/05/2026 |
| Latest Bid : 1,912.00p | Latest Ask : 1,913.00p |
| High Today : 1,928.00p | Low Today : 1,905.79p |
| This Years High : 2,208.00p | This Years Low : 1,344.00p |
| Volume : 1,762,224 | MKT Cap : £79376.75M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Add | Simon Watkins | Premium Only | 2026-05-07 10:20:00 07/05/2026 | 1.89% |
| Neutral | Citi | Premium Only | 2026-05-06 06:15:00 06/05/2026 | – |
| Hold | LBBW | Premium Only | 2026-04-30 10:42:00 30/04/2026 | -1.39% |
| Underweight | Barclays | Premium Only | 2026-04-30 05:48:00 30/04/2026 | -0.42% |
| Neutral | Goldman Sachs | Premium Only | 2026-04-30 05:10:00 30/04/2026 | – |